MyJournals Home  

RSS FeedsSotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes (Diabetes Technology & Therapeutics)

 
 

23 august 2019 07:00:12

 
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes (Diabetes Technology & Therapeutics)
 


Diabetes Technology & Therapeutics, Volume 21, Issue 9, Page 471-477, September 2019.


 
205 viewsCategory: Biotechnology, Medicine
 
Engagement and Weight Loss: Results from the Mobile Health and Diabetes Trial (Diabetes Technology & Therapeutics)
Evolving Management Strategies for Nonalcoholic Fatty Liver Disease-Targeting Primary Care Physicians (Diabetes Technology & Therapeutics)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Medicine


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten